Yahoo Web Search

    • Is Novavax a Buy?

      Is Novavax a Buy?

      Motley Fool· 4 days ago

      In the race to develop COVID-19 vaccines, Novavax (NASDAQ: NVAX) seems to have gotten the most important part right. The latest clinical trial data for...

    • Unusual Options Activity Insight: GlaxoSmithKline

      Benzinga· 6 days ago

      On Monday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved down to $39.13. Exceptionally large volume (compared ...

    • GSK Expects Smaller Drop in Profit for 2021

      WFMZ Eastern Pennsylvania and Western New Jersey· 4 days ago

      GlaxoSmithKline and its CEO, Emma Walmsley, have been criticized for lackluster performance compared to other large pharma companies.